Ackermans & van Haaren: Another Delen Private Bank acquisition in the Netherlands. Ahold Delhaize: Peer Albertsons FY24/25 results. ASML: 1Q25 results; already weaker ahead of the tariffs. Barco: Calm before the storm. Heineken: In the hold. Melexis: Partial move to China. Staffing sector: Hays' 3Q24/25 trading update; in line. Vopak: New industrial terminal or energy transition facility? WDP: €60m investment with KDL
Melexis announced the next step in its China strategy – a move designed to further strengthen its commitment to the rapidly growing and innovative Chinese market: expanding on its existing operations by establishing a locally embedded logistics hub and end-to-end local manufacturing in China. Melexis indicated that the strategy represents a significant enhancement that reinforces their customer-first philosophy. With this announcement, Melexis continues and even expands its strategic roadmap in ...
In this sector note we take a close look at the semiconductor universe and go over end market dynamics, semi manufacturing trends and the impact on the WFE market. We provide detailed overviews of historical market trends and short term adjustments. We show that lower demand from China is a real risk for the WFE market, as we don't expect the non-China WFE revenues will increase with 28% y/y in 2025, which CSS implies. Our analysis shows a clear 10% risk on WFE estimates based on fundamentals, e...
We have updated our model to assess the impact of Trump's tariffs and his U-turn of yesterday. Consequently, we are lowering our Target Price to €70 (previously €76) while maintaining our Buy-rating. Please note that Melexis remains part of the KBC Securities' Dynamic Top Pick List, and we continue to hold a positive outlook. Although Melexis' direct sales to the US account for approximately half of the 9% of FY24 NALA sales, the other half is attributed to clients in Canada and Mexico, with th...
A director at EXMAR NV bought 64,842 shares at 11.500EUR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
Trumps reciprocal tariffs caused a massive blow to equity markets, following a pressured period of escalating trade wars. Retaliatory measures can further heavily damage market confidence, as seen Friday when China announced their 34% tarrif of US goods. International trade policies have never moved this erratic and untransparant, with uncertainty and volatility being the baseline for now. In this report we highlight the key stocks in our coverage relevant to this discussion.
In this April 2025 update of the KBC Securities' Dynamic Top Pick List, we are removing Gimv and adding Adyen. Since adding Gimv to the Dynamic Top Pick List in mid-December 2024, Gimv's performance has remained flat. However, month-to-date, it has increased by nearly 7%, while the indices have all declined. Given the backdrop of a tariff war brewing, we think it's time to remove Gimv from the Dynamic Top Pick List as medium-sized businesses are more likely to feel the pinch of lower demand and...
Melexis: update on the share buy-back program Press release - Regulated Information Ieper, Belgium – 31 March 2025, 17.45 hrs CET Further to the initiation of the share buy-back program announced on 10 December 2024, Melexis reports the purchase of 34,000 Melexis shares on Euronext Brussels in the period from 24 to 28 March 2025. Trade dateTotal shares purchasedAverage price (€)Min price (€)Max price (€)Buyback amount (€)24/3/20256,00056.8356.1057.10340,98725/3/20256,00057.3556.7057.75344,07426/3/20257,00056.0655.7057.30392,39227/3/20259,00054.1653.9055.45487,47128/3/20256,00053.5353.10...
Melexis: update over het aandeleninkoopprogramma Persbericht - Gereglementeerde informatie Ieper, België – 31 maart 2025, 17.45 uur CET Naar aanleiding van het aandeleninkoopprogramma dat op 10 december 2024 werd aangekondigd, maakt Melexis bekend dat er 34.000 eigen aandelen ingekocht werden op Euronext Brussel tussen 24 en 28 maart 2025. InkoopdatumAantal verworven aandelenGemiddelde prijs (€)Laagste prijs (€)Hoogste prijs (€)Aankoop bedrag (€)24/3/20256.00056,8356,1057,10340.98725/3/20256.00057,3556,7057,75344.07426/3/20257.00056,0655,7057,30392.39227/3/20259.00054,1653,9055,45487.47...
Melexis: update on the share buy-back program Press release - Regulated Information Ieper, Belgium – 24 March 2025, 17.45 hrs CET Further to the initiation of the share buy-back program announced on 10 December 2024, Melexis reports the purchase of 33,000 Melexis shares on Euronext Brussels in the period from 17 to 21 March 2025. Trade dateTotal shares purchasedAverage price (€)Min price (€)Max price (€)Buyback amount (€)17/3/20256,00058.9458.6059.30353,61518/3/20256,00059.7559.3060.60358,49219/3/20256,00058.8058.5559.15352,82920/3/20256,17857.5957.1058.80355,81921/3/20258,82256.1355.70...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.